Pathobiochemical implications of hyperdopaminuria in patients with aromatic L-amino acid decarboxylase deficiency

J Inherit Metab Dis. 2000 Jun;23(4):325-8. doi: 10.1023/a:1005650325003.

Authors

N G Abeling¹, C Bräutigam, G F Hoffmann, P G Barth, R A Wevers, J Jaeken, A Fiumara, A Knust, A H van Gennip

Affiliation

¹ Academic Medical Center, University of Amsterdam, Department of Clinical Chemistry and Division Emma Children's Hospital, The Netherlands. abeling@amc.uva.nl

PMID: 10896285
DOI: 10.1023/a:1005650325003

No abstract available

MeSH terms

3,4-Dihydroxyphenylacetic Acid / urine
Aromatic-L-Amino-Acid Decarboxylases / deficiency*
Dopamine / analogs & derivatives
Dopamine / urine*
Homovanillic Acid / urine
Humans
Levodopa / therapeutic use

Substances

3,4-Dihydroxyphenylacetic Acid
Levodopa
Aromatic-L-Amino-Acid Decarboxylases
3-methoxytyramine
Dopamine
Homovanillic Acid